Bio-Path Holdings, Inc.
P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION
Last updated:
Abstract:
Provided herein are methods of treating cancer or an autoimmune disease comprising administering a liposome that comprises neutral phospholipids and a P-ethoxy oligonucleotide that targets a IGF-1R-encoding polynucleotide.
Status:
Application
Type:
Utility
Filling date:
19 Apr 2018
Issue date:
6 Feb 2020